These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29135889)
1. COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMY. Scholz P; Sitnilska V; Hess J; Becker M; Michels S; Fauser S Retina; 2019 Jan; 39(1):180-185. PubMed ID: 29135889 [TBL] [Abstract][Full Text] [Related]
2. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy]. Maier M; Abraham S; Frank C; Lohmann CP; Feucht N Ophthalmologe; 2017 Feb; 114(2):148-154. PubMed ID: 27444007 [TBL] [Abstract][Full Text] [Related]
3. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome. Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823 [TBL] [Abstract][Full Text] [Related]
4. Ocriplasmin versus vitrectomy for the treatment of macular holes. Juncal VR; Chow DR; Vilà N; Kapusta MA; Williams RG; Kherani A; Berger AR Can J Ophthalmol; 2018 Oct; 53(5):441-446. PubMed ID: 30340707 [TBL] [Abstract][Full Text] [Related]